Kura Oncology KURA
NASDAQ KURA
$9.76 -0.12 (-1.21%)
As of: Oct 22, 2026 · 1:02 PM EDT

Kura Oncology (KURA) Operating Margin (2025 - 2026)

Updated

Kura Oncology (KURA) reported Operating Margin of -349.77% for Q2 2026, up 125.55 percentage points from -475.31% a year earlier and up 81.74 percentage points from the prior quarter.

Analysis

Kura Oncology (KURA) Operating Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kura Oncology's Operating Margin came in at -374.48%; for FY2025, it was -449.94%, down 91.40 percentage points from FY2024.

  • By year, Operating Margin came in at -358.55% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn 24.35%
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn 37.86%
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 20.57%
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn -133.21%
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn 28.37%
10 Kura Oncology 866.34 Mn -1.45 Bn 20.63 Mn -349.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -349.77%
Mar 31, 2026 -431.51%
Jun 30, 2025 -475.31%
Mar 31, 2025 -458.61%
API Access

Kura Oncology Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KURA&period=max&api_key=YOUR_API_KEY